WS #17033
Hims & Hers secured a GLP-1 deal with Eli Lilly, pivoting away from compounding to signal regulatory compliance and long-term stability in the weight-loss drug market. Meanwhile, Akamai surged 8% on strong CIS outlook momentum, and MARA cleared a key FERC hurdle for its $1.5B AI computing pivot. These developments highlight a broader trend where tech-adjacent companies are finding growth through strategic partnerships and infrastructure diversification, even as the broader semiconductor sector faces headwinds.
Tech Earnings & Strategic Moves
Hims & Hers secured a GLP-1 deal with Eli Lilly, pivoting away from compounding to signal regulatory compliance and long-term stability in the weight-loss drug market. Meanwhile, Akamai surged 8% on strong CIS outlook momentum, and MARA cleared a key FERC hurdle for its $1.5B AI computing pivot. These developments highlight a broader trend where tech-adjacent companies are finding growth through strategic partnerships and infrastructure diversification, even as the broader semiconductor sector faces headwinds.